Published chromatin immunoprecipitation sequencing (ChIP-seq) experiments in neuroblastoma lines show binding of GATA2 and GATA3 to cRE1 and cRE3, but not cRE2 (Extended Data Fig. 2c)1,32. This evidence concerns the gene GATA3 and neuroblastoma.